FDA: EOS Lip Balms Linked To Adverse Reactions, But Cause Is Unknown
This article was originally published in The Rose Sheet
In a March 16 post to its website, FDA says that after inspecting EOS Products' contract manufacturer, it still cannot determine why consumers are experiencing rashes, blisters and cracked lips following use of EOS Lip Balm.
You may also be interested in...
Momentum this year behind legislative proposals for cosmetics regulatory reform has prompted key Congress members to question FDA about the current oversight system. In a response to the Senate HELP Committee’s chairman, FDA provides a wealth of data on its enforcement activities and confirms hair loss as an adverse event it considers “serious,” if not one currently identified as such by MedWatch’s definition.
The Personal Care Products Council isn't counting on the Personal Care Products Safety Act to pass in 2016, but compromise efforts to reconcile that bill and the Cosmetic Modernization Amendments supported by small business could be the ticket to reform in the 115th Congress, the trade group suggests. PCPC execs discussed the current legislative landscape at the group's annual meeting in Palm Beach, Florida.
A suit filed March 17 alleges the products cause extreme and possibly permanent damage to hair, including hair loss, visible bald spots and severe breakage. In an earlier suit, the firm argued that a mandatory agreement requires customers to submit claims to binding individual arbitration rather than proceeding in court.